HandyLab, Inc.
Medical Equipment ManufacturingUnited States11-50 Employees
Learn about working at HandyLab, Inc.. Join LinkedIn today for free. See who you know at HandyLab, Inc., leverage your professional network, and get hired.
Recent Acquisition HandyLab was acquired by Becton, Dickinson & Co. in June 2020 for $275 million, indicating strong industry validation and potential for expanded distribution channels to hospitals and diagnostic labs.
Innovative Portfolio The company holds pioneering molecular diagnostic testing capabilities and patents, offering opportunities to enhance diagnostic product offerings within healthcare settings.
Market Positioning As a small company with a revenue range of 1M to 10M, HandyLab presents an attractive target for partnerships or integrations with larger healthcare companies seeking innovative diagnostic solutions.
Growth Potential Given its recent acquisition and patent portfolio, there is significant potential for product expansion, licensing, or joint ventures in molecular diagnostics and related medical equipment markets.
Industry Trends The company's focus aligns with industry shifts towards rapid, molecular-based diagnostics, providing an opportunity to address increasing demand for fast, accurate testing in medical facilities.
| HandyLab, Inc. Email Formats | Percentage |
| FLast@handylab.com | 50% |
| FLast@handylab.com | 50% |
Medical Equipment ManufacturingUnited States11-50 Employees
Learn about working at HandyLab, Inc.. Join LinkedIn today for free. See who you know at HandyLab, Inc., leverage your professional network, and get hired.
HandyLab, Inc.'s revenue is estimated to be in the range of $1M$10M
HandyLab, Inc.'s revenue is estimated to be in the range of $1M$10M